132 related articles for article (PubMed ID: 1376185)
21. Granulocyte-macrophage colony-stimulating factor accelerates hematopoietic recovery after autologous bone marrow or peripheral blood progenitor cell transplantation and high-dose chemotherapy for lymphoma.
Colombat P; Delain M; Desbois I; Domenech J; Binet C; Tabah I; Lamagnere JP; Linassier C
Bone Marrow Transplant; 1996 Aug; 18(2):293-9. PubMed ID: 8864437
[TBL] [Abstract][Full Text] [Related]
22. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[TBL] [Abstract][Full Text] [Related]
23. [Economic study of the cost of peripheral blood hematopoietic precursor autotransplantation compared with bone marrow transplantation].
Juliá A; Bueno J; Gadea N; Massuet L; del Baño C
Med Clin (Barc); 1995 Jun; 105(4):131-5. PubMed ID: 7623504
[TBL] [Abstract][Full Text] [Related]
24. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant.
Bolwell BJ; Goormastic M; Yanssens T; Dannley R; Baucco P; Fishleder A
Bone Marrow Transplant; 1994 Dec; 14(6):913-8. PubMed ID: 7536072
[TBL] [Abstract][Full Text] [Related]
25. Infusion of autologous peripheral blood nucleated cells hastens hematological recovery after high dose chemotherapy and autologous transplantation of bone marrow.
Lopez M; Mortel O; Pouillart P; Zucker JM; Fechtenbaum J; Douay L; Palangie T; Michon J; Salmon D
Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():44-5. PubMed ID: 1969310
[No Abstract] [Full Text] [Related]
26. Elevated plasma prostaglandin E2 levels found in 14 patients undergoing autologous bone marrow or stem cell transplantation.
Cayeux SJ; Beverley PC; Schulz R; Dörken B
Bone Marrow Transplant; 1993 Dec; 12(6):603-8. PubMed ID: 7907905
[TBL] [Abstract][Full Text] [Related]
27. Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation.
Bielski M; Yomtovian R; Lazarus HM; Rosenthal N
Bone Marrow Transplant; 1998 Dec; 22(11):1071-6. PubMed ID: 9877269
[TBL] [Abstract][Full Text] [Related]
28. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
Barge RM; Brouwer RE; Beersma MF; Starrenburg CW; Zwinderman AH; Hale G; Waldmann H; den Ottolander GJ; Falkenburg JH; Willemze R; Fibbe WE
Bone Marrow Transplant; 2001 May; 27(10):1053-8. PubMed ID: 11438820
[TBL] [Abstract][Full Text] [Related]
29. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease.
Abrahamsen IW; Sømme S; Heldal D; Egeland T; Kvale D; Tjønnfjord GE
Haematologica; 2005 Jan; 90(1):86-93. PubMed ID: 15642674
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cell recovery after autologous stem cell transplantation.
Damiani D; Stocchi R; Masolini P; Michelutti A; Sperotto A; Geromin A; Skert C; Cerno M; Michieli M; Baccarani M; Fanin R
Bone Marrow Transplant; 2002 Sep; 30(5):261-6. PubMed ID: 12209346
[TBL] [Abstract][Full Text] [Related]
31. Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients.
Hammarström V; Pauksen K; Björkstrand B; Simonsson B; Oberg G; Ljungman P
Bone Marrow Transplant; 1998 Jul; 22(1):67-71. PubMed ID: 9678798
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of malignant hematological diseases with autologous peripheral blood stem cell transplantation].
Zheng H; Su Y; Yuan L
Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):309-11. PubMed ID: 11243112
[TBL] [Abstract][Full Text] [Related]
33. Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation.
Bender JG; Williams SF; Myers S; Nottleman D; Lee WJ; Unverzagt KL; Walker D; To LB; Van Epps DE
Bone Marrow Transplant; 1992 Sep; 10(3):281-5. PubMed ID: 1384900
[TBL] [Abstract][Full Text] [Related]
34. [Autograft of blood stem cells].
Reiffers J; Marit G; Rice A; Boiron JM; Bernard P; Vezon G; Broustet A
Bull Cancer; 1989; 76(9):931-8. PubMed ID: 2575919
[TBL] [Abstract][Full Text] [Related]
35. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
36. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
de la Rubia J; Sanz GF; Martín G; Sempere A; Picón I; Carral A; Larrea L; Martínez J; Soler MA; Bonanad S; López F; Jarque I; Sanz MA
Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390
[TBL] [Abstract][Full Text] [Related]
37. Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation.
Torres A; Sánchez J; Lakomsky D; Serrano J; Alvarez MA; Martín C; Valls C; Nevado L; Rodriguez A; Casaño J; Martínez F; Gómez P
Haematologica; 2001 Jan; 86(1):24-9. PubMed ID: 11146566
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s).
Siena S; Bregni M; Bonsi L; Strippoli P; Peccatori F; Magni M; Di Nicola M; Bagnara GP; Massimo Gianni A
Stem Cells; 1993 Jul; 11 Suppl 2():72-5. PubMed ID: 8104618
[TBL] [Abstract][Full Text] [Related]
39. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
40. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
